Evidence map›Paper›PMID 42669686›Full record

ArticleNature communications2026

ERH elicits cell lineage restriction in mammalian preimplantation development and differentiation from pluripotency via H3K9me3-heterochromatin.

Andrew Katznelson, Blake Hernandez, Kylea Tapia, Holly Fahning, Adam Burton, Jingchao Zhang, Maria-Elena Torres-Padilla, Nicolas Plachta, Kenneth S Zaret, Ryan L McCarthy

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Andrew KatznelsonInstitute for Regenerative Medicine and Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Blake HernandezInstitute for Regenerative Medicine and Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kylea TapiaCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA.
Holly FahningCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA.
Adam BurtonInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München D-81377, München, Germany.ORCID 0000-0003-1464-984X
Jingchao ZhangInstitute for Regenerative Medicine and Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Maria-Elena Torres-PadillaInstitute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München D-81377, München, Germany.
Nicolas PlachtaInstitute for Regenerative Medicine and Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kenneth S ZaretInstitute for Regenerative Medicine and Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. zaret@pennmedicine.upenn.edu.ORCID 0000-0001-8932-3145
Ryan L McCarthyCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA. Ryan.McCarthy@seattlechildrens.org.ORCID 0000-0003-4645-3526

Funding

Revealing how cytoskeletal dynamics form the early mammalian embryoR01HD102013 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI PLACHTA, NICOLAS · 2021 to 2025
$2.5M
Transcription Factors Overcoming Chromatin Barriers to Control Cell FateR35GM153180 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Kenneth Zaret · 2024 to 2026
$2.2M
Revealing how the mitotic spindle controls asymmetric cell division in vivoR01GM139970 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI PLACHTA, NICOLAS DANIEL · 2020 to 2023
$1.8M
Modifying regulators of heterochromatin to improve reprogramming to functional hepatocytesK01DK117970 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MCCARTHY, RYAN LEHMAN · 2018 to 2022
$527k
NICHD NIH HHS R01 HD102013NIDDK NIH HHS K01 DK117970NIGMS NIH HHS R01 GM139970NIGMS NIH HHS R35 GM153180U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) HD102013-01A1U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) DK117970-01U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM139970-01U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM153180
6 · The paper itself

Abstract

Enhancer of Rudimentary Homolog (ERH) is an evolutionarily conserved protein originally characterized as promoting fission yeast heterochromatin and recently shown to maintain H3K9me3 heterochromatin in human fibroblasts. Here, we find that ERH depletion in fibroblasts reverts the somatic cell H3K9me3 landscape of broad megabase size domains to an embryonic stem cell (ESC) state composed of mainly H3K9me3 peaks and enables activation of naïve and pluripotency genes and transposable elements during induced pluripotent stem cell (iPSC) reprogramming. Concordantly, we find that ERH represses totipotent and alternative lineage programs during mouse preimplantation development and is required for proper segregation of the inner cell mass and trophectoderm cell lineages. During human ESC differentiation into germ layer lineages, ERH silences naïve and pluripotency genes, transposable elements, and alternative lineage somatic genes. As in fission yeast, we find that mammalian ERH interacts with RNA-binding proteins to engage and repress its chromatin targets. Our findings reveal a conserved, fundamental role for ERH in mammalian cell fate specification via the initiation and maintenance of early developmental gene repression.

Indexed as

Cell Cycle ProteinsCell DifferentiationCell LineageEmbryonic DevelopmentHeterochromatinHistonesTranscription FactorsAnimalsEmbryonic Stem CellsGene Expression Regulation, DevelopmentalHumansInduced Pluripotent Stem CellsMiceCell Cycle ProteinsHeterochromatinHistonesTranscription Factors

Identifiers

PMID42669686
PMCPMC13526840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.